Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Hypha Labs (FUNI) Current Deferred Revenue (2018 - 2019)

Historic Current Deferred Revenue for Hypha Labs (FUNI) over the last 7 years, with Q1 2019 value amounting to $500.0.

  • Hypha Labs' Current Deferred Revenue fell 7222.22% to $500.0 in Q1 2019 from the same period last year, while for Mar 2019 it was $500.0, marking a year-over-year decrease of 7222.22%. This contributed to the annual value of $525.0 for FY2018, which is N/A changed from last year.
  • As of Q1 2019, Hypha Labs' Current Deferred Revenue stood at $500.0, which was down 7222.22% from $1750.0 recorded in Q4 2018.
  • Hypha Labs' Current Deferred Revenue's 5-year high stood at $174918.0 during Q2 2015, with a 5-year trough of $500.0 in Q1 2019.
  • Over the past 3 years, Hypha Labs' median Current Deferred Revenue value was $2328.0 (recorded in 2015), while the average stood at $42327.6.
  • Examining YoY changes over the last 5 years, Hypha Labs' Current Deferred Revenue showed a top increase of 8685.25% in 2015 and a maximum decrease of 9597.11% in 2015.
  • Quarter analysis of 3 years shows Hypha Labs' Current Deferred Revenue stood at $2328.0 in 2015, then decreased by 24.83% to $1750.0 in 2018, then crashed by 71.43% to $500.0 in 2019.
  • Its Current Deferred Revenue stands at $500.0 for Q1 2019, versus $1750.0 for Q4 2018 and $525.0 for Q3 2018.